US Stock MarketDetailed Quotes

ARTV Artiva Biotherapeutics

Watchlist
  • 11.200
  • +0.325+2.99%
Close Nov 22 16:00 ET
  • 11.200
  • 0.0000.00%
Post 16:00 ET
272.04MMarket Cap-4439P/E (TTM)

About Artiva Biotherapeutics Company

Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA.

Company Profile

SymbolARTV
Company NameArtiva Biotherapeutics
Listing DateJul 19, 2024
Issue Price12.00
Founded2019
CEODr. Fred Aslan, M.D.
MarketNASDAQ
Employees81
Fiscal Year Ends12-31
Address5505 Morehouse Drive,Suite 100
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-267-4467
Websitehttp://www.artivabio.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Fred Aslan, M.D.
  • President, Chief Executive Officer and Director
  • 1.11M
  • Neha Krishnamohan
  • Executive Vice President, Corporate Development, Chief Financial Officer and Principal Accounting Officer
  • --
  • Christopher Horan
  • Chief Technical Operations Officer
  • 726.90K
  • Jennifer Kinsbruner Bush
  • Chief Operating Officer, Chief Legal Officer, Corporate Secretary and Compliance Officer
  • 725.83K
  • Thorsten Graef, M.D.,PhD
  • Chief Medical Officer
  • --
  • Dr. Heather Raymon, PhD
  • Senior Vice President, Research and Early Development
  • --
  • Dr. Brian Daniels,M.D.
  • Chairman of the Board
  • --
  • Yong-Jun Huh
  • Director
  • --
  • James Jong-eun Park
  • Director
  • --
  • Dr. Alison Moore, PhD
  • Director
  • --
  • Dr. Diego Miralles, M.D.
  • Director
  • --
  • Elizabeth L. Hougen
  • Independent Director
  • --
  • Dr. Yvonne Yamanaka, PhD
  • Independent Director
  • --
  • Dr. Laura Stoppel, PhD
  • Independent Director
  • --
  • Dr. Laura Bessen, M.D.
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Recent IPOs
Recent IPOs
Intraday+1.96%